Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

October 31, 2009

Conditions
Dermatitis, Contact
Interventions
BIOLOGICAL

TRUE Test allergens Fragrance Mix and Thimerosol

"* Thimerosal, 0.008 mg/cm2 in hydroxypropylcellulose~* Thimerosal, 0.008 mg/cm2 in polyvinylpyrrolidone~* Fragrance mix, 0.43 mg/cm2 in hydroxypropylcellulose with β-cyclodextrin~* Fragrance mix, 0.43 mg/cm2 in polyvinylpyrrolidone with β-cyclodextrin~Patches are placed at day one and removed 48 hours. The duration of the study lasts 21 days. However, the subject is only exposed the the study allergen for 48 hours."

Trial Locations (4)

11501

Winthrop University Hospital, Mineola

66216

American Dermatology Associates, Shawnee Mission

72205

River City Dermatology, Little Rock

40202-1864

Dermatology Specialists PSC, Louisville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allerderm

INDUSTRY

NCT00612768 - Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations | Biotech Hunter | Biotech Hunter